/

Sociétés

Je

Non vérifié

Jeito Capital

Ce que nous écrivons

Annonces ÉconomiquesBiotechnologieFinanceIndustrie pharmaceutiquePublicité/Marketing/Médias/Communication

14 communiqués de presse

Voir tous les communiqués de presse

05/05/2026

Marché du travail

Industrie

Science

Ressources Humaines

Finance

Associations/Professionnels

Biotechnologie

Santé

Industrie pharmaceutique

Jeito Capital Bolsters Its Leadership Team With the Appointment of Elaine Caughey, MBA, as Partner, Business Development and Investor Relations, and Sarah Shackelton, MPA, as Partner, Talent

Source

Émetteur

1.00

0

14/04/2026

Biotechnologie

Industrie pharmaceutique

Santé

Oncologie

Jeito Capital leads oversubscribed $75 million Series C in Adcendo ApS to Advance its First- and Best-in-class Clinical ADC1 Pipeline in Oncology

Source

Émetteur

1.00

0

08/04/2026

Cardiologie

Biotechnologie

Industrie pharmaceutique

Oncologie

Santé

Organisation d'Entreprise

Associations/Professionnels

Jeito Capital Hits Record $1.2 Billion (€1 Billion)1 Close for Jeito II Fund to Drive Breakthrough Therapeutic Innovation for Patients

Source

Émetteur

1.00

0

24/02/2026

Finance

Annonces Économiques

Publicité/Marketing/Médias/Communication

Jeito Capital Makes Significant Investment in the Second Closing of Alveus Therapeutics’ Oversubscribed Series A, Bringing Total Financing to $197 Million

Source

Émetteur

1.00

0

15/10/2025

Finance

Publicité/Marketing/Médias/Communication

Annonces Économiques

Jeito Capital promotes Ksenija Pavletic to General Partner

Source

Émetteur

1.00

0

10/09/2025

Finance

Annonces Économiques

Jeito Capital announces significant participation in oversubscribed $213M Series D financing for Odyssey Therapeutics to advance clinical pipeline addressing autoimmune diseases with high unmet needs

Source

Émetteur

1.00

0

20/05/2025

Finance

Publicité/Marketing/Médias/Communication

Annonces Économiques

Jeito Capital Leads a USD 65 million Financing in ReproNovo to Develop Transformational Treatments in Reproductive Medicine and Women’s Health

Source

Émetteur

1.00

0

12/05/2025

Finance

Publicité/Marketing/Médias/Communication

Annonces Économiques

Jeito Capital leads EUR 132 million oversubscribed Series B financing in Azafaros to advance Phase 3 clinical programs of innovative therapies in rare inherited neuro-metabolic disorders

Source

Émetteur

1.00

0

11/05/2025

Finance

Annonces Économiques

Jeito Capital Strengthens Leadership for Next Chapter of Growth: Mehdi Ainouche Promoted to Partner, Julien Elric to Senior Principal

Source

Émetteur

1.00

0

23/03/2025

Finance

Publicité/Marketing/Médias/Communication

Annonces Économiques

Jeito Capital co-leads the oversubscribed €78 million financing in Augustine Therapeutics to develop novel therapies for neuromuscular, cardio-metabolic and neurodegenerative diseases

Source

Émetteur

1.00

0

Followers

0

Compatibilité

0